Literature DB >> 2902893

Release of [3H]-noradrenaline from the sympathetic nerves to bovine mesenteric lymphatic vessels and its modification by alpha-agonists and antagonists.

J M Allen1, J G McCarron, N G McHale, K D Thornbury.   

Abstract

1. Isolated segments of bovine mesenteric lymphatic vessels were loaded with [3H]-noradrenaline and its efflux in response to field stimulation examined. Vessels were attached to an isometric force transducer for the simultaneous recording of mechanical activity. 2. Field stimulation at 1, 4 and 8 Hz (0.3 ms pulses, 1 min train) increased spontaneous contraction rate and evoked 3H release up to a maximum of 4.5% of total tissue 3H at 8 Hz. Output per pulse was maximal at 4 Hz. 3. Tetrodotoxin (3 x 10(-6) M) blocked the release of 3H in response to field stimulation although the drug did not attenuate release evoked by high K+ (65 mM) solution. Field-evoked release of 3H was also absent in Ca2+ -free solution containing EGTA (1 mM). 4. When vessels were preincubated with labelled transmitter plus cocaine (5 x 10(-5) M) evoked release of 3H was absent. After preloading with [3H]-noradrenaline, cocaine (10(-6) M) potentiated both the mechanical response to field stimulation and evoked 3H release. 5. The relatively non selective alpha-adrenoceptor antagonist phentolamine (3 x 10(-6) M) and the alpha 2-antagonists yohimbine (10(-8) M) and rauwolscine (10(-6) M) significantly increased evoked 3H release at both of the frequencies examined (1 and 4 Hz). In contrast, the selective alpha 1-antagonist prazosin (10(-6) M) failed to alter 3H release to 4 Hz stimulation although release at 1 Hz was potentiated in the presence of the drug. 6. The postsynaptic excitatory response to field stimulation remained in the presence of prazosin (10(-6) M), but was converted to an inhibitory effect in the presence of phentolamine (3 x 10(-6) M), yohimbine (10(-6) M) or rauwolscine (10(-6) M). 7. Evoked 3H efflux was significantly reduced by clonidine (10(-6) M), xylazine (10(-6) M) and exogenous noradrenaline (5 x 10(-7) M), although phenylephrine (10(-6) M) reduced release only at the lower of the two frequencies tested (1 Hz). 8. These findings suggest that release of 3H by field stimulation reflects endogenous transmitter release and that this is subject to autoinhibition via feedback onto inhibitory prejunctional alpha 2-adrenoceptors. The postjunctional excitatory response is mediated via postjunctional alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902893      PMCID: PMC1854041          DOI: 10.1111/j.1476-5381.1988.tb11593.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  FACILITATION OF TRANSMISSION FROM AUTONOMIC NERVE TO SMOOTH MUSCLE OF GUINEA-PIG VAS DEFERENS.

Authors:  G BURNSTOCK; M E HOLMAN; H KURIYAMA
Journal:  J Physiol       Date:  1964-07       Impact factor: 5.182

2.  Selective metabolic pathways for noradrena-line in the peripheral and in the central nervous system.

Authors:  S Z Langer
Journal:  Med Biol       Date:  1974-12

3.  The release of H3-norepinephrine in arterial strips studied by the technique of superfusion and transmural stimulation.

Authors:  C Su; J A Bevan
Journal:  J Pharmacol Exp Ther       Date:  1970-03       Impact factor: 4.030

4.  The release of noradrenaline by the sympathetic post-ganglionic nerves to the spleen of the cat in response to low frequency stimulation.

Authors:  B N Davies; P G Withrington
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-01

5.  Intrinsic contractility of lymphatics in sheep and in dogs.

Authors:  T Campbell; T Heath
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1973-07

6.  Comparison of secretion of sympathetic neurotransmitter induced by nerve stimulation with that evoked by high potassium, as triggers of dual alpha-adrenoceptor mediated negative feed-back control of noradrenaline secretion.

Authors:  L Stjärne
Journal:  Prostaglandins       Date:  1973-04

7.  Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxybenzamine and desipramine.

Authors:  C Su; J A Bevan
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

8.  Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat.

Authors:  W Haefely; A Hürlimann; H Thoenen
Journal:  J Physiol       Date:  1965-11       Impact factor: 5.182

9.  Variation in noradrenaline output with changes in stimulus frequency and train length: role of different noradrenaline pools.

Authors:  J Hughes; R H Roth
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

10.  Release of noradrenaline from the cat spleen by potassium.

Authors:  S M Kirpekar; A R Wakade
Journal:  J Physiol       Date:  1968-02       Impact factor: 5.182

View more
  5 in total

Review 1.  Experimental Models Used to Assess Lymphatic Contractile Function.

Authors:  Scott D Zawieja; Jorge A Castorena-Gonzalez; Brandon Dixon; Michael J Davis
Journal:  Lymphat Res Biol       Date:  2017-12       Impact factor: 2.589

2.  Mediation of excitatory neurotransmission by the release of ATP and noradrenaline in sheep mesenteric lymphatic vessels.

Authors:  M A Hollywood; N G McHale
Journal:  J Physiol       Date:  1994-12-01       Impact factor: 5.182

3.  Beta-adrenoceptor-mediated facilitation of [3H]-noradrenaline release from the intramural nerves of bovine mesenteric lymphatic vessels.

Authors:  J M Allen; J G McCarron; N G McHale; K D Thornbury
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

4.  Morphological and Molecular Characterization of Human Dermal Lymphatic Collectors.

Authors:  Viktoria Hasselhof; Anastasia Sperling; Kerstin Buttler; Philipp Ströbel; Jürgen Becker; Thiha Aung; Gunther Felmerer; Jörg Wilting
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 5.  Drug-Related Lymphedema: Mysteries, Mechanisms, and Potential Therapies.

Authors:  Soumiya Pal; Jenat Rahman; Shengyu Mu; Nancy J Rusch; Amanda J Stolarz
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.